Task Force 10: Clinical Considerations for the Care of Masters Athletes with Underlying Cardiovascular Disease

Masters athletes are individuals ≥35 yr of age who place a high premium on exercise training and competition. This document details important cardiovascular conditions, risk factors, and data-driven discussion, which serve as the rationale for Section X from the 2025 AHA/ACC Scientific Statement: Clinical Considerations for Competitive Sports Participation for Athletes Cardiovascular Abnormalities. Disease-specific risk stratification and shared decision-making are the cornerstones for Masters athletes when considering competitive sports participation. Coronary artery disease, atrial fibrillation, incidental myocardial fibrosis, aortic enlargement and aneurysms, and valvular heart disease are included in this Task Force document.

Authors

Institutions

Publication Details

Journal
Medicine & Science in Sports & Exercise
Published
2026-11-13
DOI
https://doi.org/10.1249/mss.0000000000004098
Primary Topic
Cardiovascular Effects of Exercise
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Task Force 10: Clinical Considerations for the Care of Masters Athletes with Underlying Cardiovascular Disease

Eugene H. Chung, Elizabeth H. Dineen, Jonathan H. Kim, Aaron Leigh Baggish et al.
3 links
Medicine & Science in Sports & Exercise
Cardiovascular Effects of Exercise
article

Task Force 10: Clinical Considerations for the Care of Masters Athletes with Underlying Cardiovascular Disease

Eugene H. Chung, Elizabeth H. Dineen, Jonathan H. Kim, Aaron Leigh Baggish, Mats B rjesson, Paul D. Thompson, Thijs M H Eijsvogels, BENJAMIN D. LEVINE
article en

Abstract

Masters athletes are individuals ≥35 yr of age who place a high premium on exercise training and competition. This document details important cardiovascular conditions, risk factors, and data-driven discussion, which serve as the rationale for Section X from the 2025 AHA/ACC Scientific Statement: Clinical Considerations for Competitive Sports Participation for Athletes Cardiovascular Abnormalities. Disease-specific risk stratification and shared decision-making are the cornerstones for Masters athletes when considering competitive sports participation. Coronary artery disease, atrial fibrillation, incidental myocardial fibrosis, aortic enlargement and aneurysms, and valvular heart disease are included in this Task Force document.

Medicine & Science in Sports & ExerciseVol. 58(12)
Hartford Hospital (US), Harvard University (US), Emory University (US), Sahlgrenska University Hospital (SE), Radboud University Medical Center (NL), Massachusetts General Hospital (US), Institute for Exercise and Environmental Medicine (US), Mayo Clinic in Florida (US), The University of Texas Southwestern Medical Center (US), University of Gothenburg (SE), University of Lausanne (CH)
Good health and well-being
Cardiovascular Effects of Exercise
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon